Mrs Shannon Mcnally Wallace, MSW, LCSW, LCAS, CCS | |
Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180-3100 | |
(314) 590-5022 | |
Not Available |
Full Name | Mrs Shannon Mcnally Wallace |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | Landstuhl Regional Medical Center, Apo, Armed Forces Europe |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326290982 | NPI | - | NPPES |
6007780 | Medicaid | NC |
Mailing Address | Practice Location Address |
---|---|
Mrs Shannon Mcnally Wallace, MSW, LCSW, LCAS, CCS Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180-3100 Ph: (314) 590-5022 | Mrs Shannon Mcnally Wallace, MSW, LCSW, LCAS, CCS Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180-3100 Ph: (314) 590-5022 |
News Archive
P.A.D. occurs when arteries in the legs become narrowed or clogged with fatty deposits, reducing blood flow to the legs. This can result in leg muscle pain when walking, disability, amputation, and poor quality of life. Blocked arteries found in people with P.A.D. can be a red flag that other arteries, including those in the heart and brain, may also be blocked - increasing the risk of a heart attack or stroke.
Retrophin, Inc. today announced the completion of the previously announced acquisition of Manchester Pharmaceuticals LLC for a total of $62.5 million, including an upfront payment of $29.5 million, plus other payments based on product sales.
Higher levels of the omega-3 fatty acid eicosapentaenoic acid (EPA) found in the blood—and not a decrease in triglyceride levels as originally thought—appear to explain the striking reductions in cardiovascular events and deaths seen among people taking 4 grams daily of the prescription fish oil, icosapent ethyl, according to findings from a REDUCE-IT substudy presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology
Eisai Inc. announced today results from an investigational Phase 2 trial which showed that lenvatinib, when used in combination with everolimus, significantly extended progression-free survival (PFS) in patients with metastatic renal cell carcinoma (mRCC) versus everolimus alone.
› Verified 7 days ago
Heather R Baral, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Unit 23746, Apo, AE 09034 Phone: 160-209-0423 | |
Linda Riddle, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg Unit 3215, Apo, AE 09094 Phone: 314-479-2666 | |
Mark Wesseler, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-2015 | |
Mrs. Thin Phyu Bur, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 852 Mds/sg, Unit 3503, Apo, AE 09104 Phone: 314-458-3378 | |
Andrea Lynne Galeucia, LICSW; BCD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg, Unit 3215, Ramstein Ab, Apo, AE 09094 Phone: 314-479-2390 | |
Mrs. Katheryn Rose Barry, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: Unit 3240 Box 445, Apo, AE 09094 Phone: 063-714-76951 | |
Johanna Echigo, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Psc 2 Box 11102, Apo, AE 09012 Phone: 314-479-2390 |